What the analyst said

JPMorgan analyst Harlan Sur raised the price target on Texas Instruments (NASDAQ: TXN) to $365 (from $340) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TXN trades at $285. The 17 analysts who set a target in the last 3 months range from $250 to $405, with a median of $330. This $365 target is 11% above the median.

12-month window: day 1 of 365, closes on October 22, 2027.

Track record

This callOpen: TXN has not reached $365 yet. This 12-month target is scored on October 22, 2027.

Firm track recordJP Morgan: 56% of its 16 targets at least a year old were reached within 12 months (#26 of 28 firms). Accuracy ranking →

Earnings reactionOne of 13 notes after Texas Instruments’s Oct 21 results: 9 of 13 raised targets. See every call →

JP Morgan on Texas Instruments

JP Morgan price targets on Texas Instruments

4 calls from January 28, 2026 to October 22, 2026. The target went from $227 to $365 (+61%). The rating stayed Buy.

JP Morgan targetTXN share price
  1. October 22, 2026 This noteTarget raised from $340 (+7%)Buy$365
  2. July 23, 2026Target raised from $280 (+21%)Buy$340
  3. April 23, 2026Target raised from $227 (+23%)Buy$280
  4. January 28, 2026Earliest call shownBuy$227
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.